MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/25424823261462546

Медицинская библиотека · Journal of Alzheimer's disease reports · 2026

Peptide vaccination for Alzheimer's disease: Immunological foundations, therapeutic potential, and translational barriers.

Chen Haoteng, Lin Yuanxiang, Kang DeZhi, Zhao Tong

СтатьяОбзорПеревод пока не подготовлен

Аннотация

In recent years, increasing attention has been directed toward the role of immune responses in the pathogenesis of Alzheimer's disease (AD). The pathological proteins amyloid-β (Aβ) and tau protein are closely associated with immune dysregulation and neuroinflammatory processes during AD progression. Peptide vaccines targeting Aβ and tau have emerged as an active immunotherapeutic strategy designed to induce antigen-specific immune responses against pathological protein aggregates, and several candidates have advanced to early-phase clinical trials. Although preliminary studies have demonstrated acceptable safety profiles and the ability to elicit immune responses, substantial challenges remain in vaccine design, epitope selection, and clinical translation. This review summarizes current progress in peptide vaccine development for AD and discusses their potential applications from an immunological perspective.

Для цитирования: Chen Haoteng, Lin Yuanxiang, Kang DeZhi, Zhao Tong. Peptide vaccination for Alzheimer's disease: Immunological foundations, therapeutic potential, and translational barriers.. Journal of Alzheimer's disease reports. 2026. DOI: 10.1177/25424823261462546.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.